Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
facilities
Manufacturing
Lilly weighs Houston as option for new $5.9B API facility
Eli Lilly is jockeying for a tax break in Texas as it weighs whether to build a $5.9 billion API facility in Houston, according to a state filing.
Fraiser Kansteiner
May 19, 2025 10:21am
Roche puts up nearly $300M to expand manufacturing in China
May 9, 2025 10:06am
CDMO Joinn wraps up purchase of Lonza biologics plant in China
Jan 23, 2025 9:45am
Nektar extends cash runway with $90M manufacturing plant sale
Nov 4, 2024 1:16pm
Vertex adds CDMO Lonza to Casgevy production network
Sep 24, 2024 9:41am
Zydus hit with FDA warning letter flagging glass contamination
Sep 11, 2024 11:42am